on Revelation Biosciences, Inc. (NASDAQ:REVB)
Revelation Biosciences Reschedules Special Meeting Due to Technical Issues
Revelation Biosciences, Inc. has announced the cancellation of its adjourned Special Meeting of Stockholders due to technical difficulties, preventing full shareholder participation. Originally postponed from October 15 to October 29, the meeting is now rescheduled with a new record date set for October 29. The meeting will occur on December 3, 2025. Revelation aims to ensure comprehensive shareholder engagement by distributing new proxy materials soon.
Revelation Biosciences, a clinical-stage life sciences firm, focuses on inflammation management through its formulation, Gemini. This announcement emphasizes the company's commitment to resolving logistical challenges in shareholder relations.
R. E.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Revelation Biosciences, Inc. news